Difference between revisions of "Template:Antiemetics"
Jump to navigation
Jump to search
blackwiki>EmausBot m (r2.7.3) (Robot: Adding ta:வார்ப்புரு:Antiemetics, zh:Template:止吐剂) |
m (64 revisions imported) |
||
| (19 intermediate revisions by 15 users not shown) | |||
| Line 3: | Line 3: | ||
| name = Antiemetics | | name = Antiemetics | ||
| title = [[Antiemetic]]s ([[ATC code A04|A04]]) | | title = [[Antiemetic]]s ([[ATC code A04|A04]]) | ||
| + | | state = {{{state|autocollapse}}} | ||
|listclass = hlist | |listclass = hlist | ||
| − | |||
| − | | group1 = [[5-HT3 antagonist|5-HT<sub>3</sub> | + | | group1 = [[5-HT3 antagonist|5-HT<sub>3</sub> serotonin ion<br/> channel antagonist]]s |
| list1 = | | list1 = | ||
* [[Alosetron]] | * [[Alosetron]] | ||
| Line 22: | Line 22: | ||
* [[Olanzapine]] | * [[Olanzapine]] | ||
* [[Ondansetron]] | * [[Ondansetron]] | ||
| − | * [[Palonosetron]] | + | * [[Palonosetron]] ([[Netupitant/palonosetron|+netupitant]]) |
| + | * [[Quetiapine]] | ||
* [[Ramosetron]] | * [[Ramosetron]] | ||
* [[Ricasetron]] | * [[Ricasetron]] | ||
| Line 28: | Line 29: | ||
* [[Zatosetron]] | * [[Zatosetron]] | ||
| − | | group2 = [[CB1 receptor|CB<sub>1</sub>]] [[ | + | | group2 = [[Serotonin antagonist|5-HT serotonin G-protein<br/> receptor antagonist]]s |
| − | | | + | | list2 = |
| + | * [[Clozapine]] | ||
| + | * [[Cyproheptadine]] | ||
| + | * [[Hydroxyzine]] | ||
| + | * [[Olanzapine]] | ||
| + | * [[Risperidone]] | ||
| + | * [[Ziprasidone]] | ||
| + | |||
| + | | group3 = [[CB1 receptor|CB<sub>1</sub>]] [[agonist]]s<br/> ([[cannabinoid]]s) | ||
| + | | list3 = | ||
* [[Dronabinol]] | * [[Dronabinol]] | ||
* [[Nabilone]] | * [[Nabilone]] | ||
| − | * [[ | + | * [[Tetrahydrocannabinol]] ([[cannabis (drug)|cannabis]]) |
| − | |||
| − | | | + | | group4 = [[Dopamine antagonist|D<sub>2</sub>/D<sub>3</sub> antagonist]]s |
| − | | | + | | list4 = |
* [[Alizapride]] | * [[Alizapride]] | ||
* [[Bromopride]] | * [[Bromopride]] | ||
| Line 43: | Line 52: | ||
* [[Domperidone]] | * [[Domperidone]] | ||
* [[Haloperidol]] | * [[Haloperidol]] | ||
| + | * [[Hydroxyzine]] | ||
* [[Itopride]] | * [[Itopride]] | ||
* [[Metoclopramide]] | * [[Metoclopramide]] | ||
| Line 48: | Line 58: | ||
* [[Prochlorperazine]] | * [[Prochlorperazine]] | ||
* [[Thiethylperazine]] | * [[Thiethylperazine]] | ||
| + | * [[Trimethobenzamide]] | ||
| − | | | + | | group5 = [[H1 antagonist|H<sub>1</sub> antagonists]] <br/>([[Histamine antagonist|antihistamines]]) |
| − | | | + | | list5 = |
* [[Cyclizine]] | * [[Cyclizine]] | ||
* [[Dimenhydrinate]] | * [[Dimenhydrinate]] | ||
* [[Diphenhydramine]] | * [[Diphenhydramine]] | ||
| − | * [[ | + | * [[Hydroxyzine]] |
| + | * [[Meclizine]] | ||
* [[Promethazine]] | * [[Promethazine]] | ||
| − | | | + | | group6 = [[Muscarinic acetylcholine receptor|mACh]] [[Receptor_Antagonist|antagonists]]<br/> ([[anticholinergic]]s) |
| − | | | + | | list6 = |
* [[Atropine]] | * [[Atropine]] | ||
| + | * [[Diphenhydramine]] | ||
| + | * [[Hydroxyzine]] (very mild) | ||
* [[Hyoscyamine]] | * [[Hyoscyamine]] | ||
* [[Scopolamine]] | * [[Scopolamine]] | ||
| − | | | + | | group7 = [[NK1 receptor antagonist|NK<sub>1</sub> antagonists]] |
| − | | | + | | list7 = |
* [[Aprepitant]] | * [[Aprepitant]] | ||
* [[Casopitant]] | * [[Casopitant]] | ||
| Line 70: | Line 84: | ||
* [[Fosaprepitant]] | * [[Fosaprepitant]] | ||
* [[Maropitant]] | * [[Maropitant]] | ||
| + | * [[Netupitant]] | ||
| + | * [[Rolapitant]] | ||
* [[Vestipitant]] | * [[Vestipitant]] | ||
| − | | | + | | group8 = Others |
| − | | | + | | list8 = |
* [[Cerium oxalate]] | * [[Cerium oxalate]] | ||
* [[Dexamethasone]] | * [[Dexamethasone]] | ||
| Line 79: | Line 95: | ||
* [[Midazolam]] | * [[Midazolam]] | ||
* [[Propofol]] | * [[Propofol]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
}}<noinclude> | }}<noinclude> | ||
| + | {{collapsible option}} | ||
[[Category:Antiemetics]] | [[Category:Antiemetics]] | ||
| − | [[Category: | + | [[Category:Drug templates by ATC]] |
| − | |||
| − | |||
| − | |||
</noinclude> | </noinclude> | ||
Latest revision as of 14:17, 22 October 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Antiemetics|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Antiemetics|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Antiemetics|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.